SCHEMBL456324

SCHEMBL456324

COc1cccc(CCC(=O)Oc2cc(O)cc(O)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.58
GABRG2 P18507 1/20 0.58
GABRB3 P28472 1/20 0.58
GABRA3 P34903 1/20 0.58
GABRA2 P47869 1/20 0.58
GABRB2 P47870 1/20 0.58
HDAC1 Q13547 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
AKR1C3 P42330 2/20 0.49
MTNR1A P48039 2/20 0.49
MTNR1B P49286 2/20 0.49
TAAR1 Q96RJ0 1/20 0.49
GAA P10253 1/20 0.48
CYP1A2 P05177 1/20 0.48
AKR1C2 P52895 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28121828 0.87 KMT2A (0.58) HDAC1HDAC6AKR1C3MTNR1AMTNR1B
SCHEMBL457499 0.86 GPR84 (0.51) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL457128 0.84 SLC5A1 (0.62) ALDH1A1MAPTTDP1
SCHEMBL63100 0.82 HDAC1 (0.61) HDAC1HDAC6MTNR1AMTNR1BTAAR1
SCHEMBL455030 0.82 KMT2A (0.59) HDAC1AKR1C3GAAALDH1A1MAPT
SCHEMBL454743 0.82 FFAR1 (0.46) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL27570217 0.81 GAA (0.61) AKR1C3GAACYP1A2ALDH1A1MAPT
SCHEMBL30574244 0.81 GABRA1 (0.87) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL29059722 0.80 HDAC1 (0.52) HDAC1HDAC6MTNR1AMTNR1BTAAR1
SCHEMBL456323 0.79 SLC5A1 (0.72) GABRA1GABRG2GABRB3GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10800725-B2 Arylpropionyl-triketone antibacterial agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-10-13 US disclosed
US-9517994-B2 Antibacterial agents: phloroglucinol derivatives RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-12-13 US disclosed
US-20150011647-A1 ANTIBACTERIAL AGENTS: PHLOROGLUCINOL DERIVATIVES HOWARD HUGHES MEDICAL INSTITUTE 2015-01-08 US disclosed
US-20130289128-A1 ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-10-31 US disclosed
WO-2013103969-A1 ANTIBACTERIAL AGENTS: PHLOROGLUCINOL DERIVATIVES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-07-11 WO disclosed
WO-2012033846-A1 ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130289128-A1 ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS POLR2H, POLR2A, POLR2E GABRA1 3716/4885GABRG2 4352/4885GABRB3 3832/4885
US-20150011647-A1 ANTIBACTERIAL AGENTS: PHLOROGLUCINOL DERIVATIVES BET1, MRPL21, PHF6 GABRA1 4734/4885GABRG2 4323/4885GABRB3 4513/4885
US-10800725-B2 Arylpropionyl-triketone antibacterial agents POLR2H, POLR2A, POLR2E GABRA1 3716/4885GABRG2 4352/4885GABRB3 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.